PT91094A - Metodo de diagnostico de infeccoes virais associadas com a fadiga cronica - Google Patents
Metodo de diagnostico de infeccoes virais associadas com a fadiga cronicaInfo
- Publication number
- PT91094A PT91094A PT91094A PT9109489A PT91094A PT 91094 A PT91094 A PT 91094A PT 91094 A PT91094 A PT 91094A PT 9109489 A PT9109489 A PT 9109489A PT 91094 A PT91094 A PT 91094A
- Authority
- PT
- Portugal
- Prior art keywords
- chronic
- fadiga
- diagnosis
- viral infections
- infections associated
- Prior art date
Links
- 208000036142 Viral infection Diseases 0.000 title 1
- 230000001684 chronic effect Effects 0.000 title 1
- 238000003745 diagnosis Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 108091032973 (ribonucleotides)n+m Proteins 0.000 abstract 2
- 102000040650 (ribonucleotides)n+m Human genes 0.000 abstract 2
- 206010008874 Chronic Fatigue Syndrome Diseases 0.000 abstract 2
- 208000029766 myalgic encephalomeyelitis/chronic fatigue syndrome Diseases 0.000 abstract 2
- 108091034117 Oligonucleotide Proteins 0.000 abstract 1
- 230000002093 peripheral effect Effects 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Analytical Chemistry (AREA)
- Neurology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pathology (AREA)
- Biophysics (AREA)
- Psychiatry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Hospice & Palliative Care (AREA)
- Physics & Mathematics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22076588A | 1988-07-07 | 1988-07-07 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PT91094A true PT91094A (pt) | 1990-02-08 |
| PT91094B PT91094B (pt) | 1995-01-31 |
Family
ID=22824871
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT91094A PT91094B (pt) | 1988-07-07 | 1989-07-07 | Metodo de diagnostico de infeccoes virais associadas com a fadiga cronica |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP0350151B1 (pt) |
| CN (1) | CN1056747C (pt) |
| AT (1) | ATE103493T1 (pt) |
| AU (2) | AU3781189A (pt) |
| CA (1) | CA1336685C (pt) |
| DE (1) | DE68914201T2 (pt) |
| DK (1) | DK332289A (pt) |
| ES (2) | ES2066847T3 (pt) |
| IE (1) | IE63927B1 (pt) |
| IL (1) | IL90875A (pt) |
| NZ (1) | NZ229849A (pt) |
| PT (1) | PT91094B (pt) |
| ZA (1) | ZA895143B (pt) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUT65370A (en) * | 1989-10-16 | 1994-05-02 | Hem Res Inc | Diagnosis and treatment of neuro-cognitive disorders associated with systemic immunological malfunction |
| GB9108085D0 (en) * | 1991-04-16 | 1991-06-05 | Scras | Complexes of polyadenylic acid with polyuridylic acid |
| US5776690A (en) * | 1996-10-07 | 1998-07-07 | Vojdani; Aristo | Detection of chronic fatigue syndrome by decreased levels of RNase L inhibitor mRNA |
| US6506559B1 (en) | 1997-12-23 | 2003-01-14 | Carnegie Institute Of Washington | Genetic inhibition by double-stranded RNA |
| AUPP249298A0 (en) | 1998-03-20 | 1998-04-23 | Ag-Gene Australia Limited | Synthetic genes and genetic constructs comprising same I |
| WO1999049029A1 (en) | 1998-03-20 | 1999-09-30 | Benitec Australia Ltd | Control of gene expression |
| EP1147204A1 (en) | 1999-01-28 | 2001-10-24 | Medical College Of Georgia Research Institute, Inc. | Composition and method for in vivo and in vitro attenuation of gene expression using double stranded rna |
| US6423885B1 (en) | 1999-08-13 | 2002-07-23 | Commonwealth Scientific And Industrial Research Organization (Csiro) | Methods for obtaining modified phenotypes in plant cells |
| CA2369944A1 (en) | 2001-01-31 | 2002-07-31 | Nucleonics Inc. | Use of post-transcriptional gene silencing for identifying nucleic acid sequences that modulate the function of a cell |
| WO2010104571A2 (en) * | 2009-03-13 | 2010-09-16 | Hemispherx Biopharma, Inc. | Treating chronic fatigue syndrome and prolonged qt interval |
| EP3652542A1 (en) * | 2017-07-14 | 2020-05-20 | Protea Biopharma N.V. | Methods and means for diagnosing and/or treating a fatiguing illness |
| EP3893893A1 (en) * | 2018-12-13 | 2021-10-20 | Aim Immunotech Inc. | Methods for improving exercise tolerance in myalgic encephalomyelitis patients |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1326450C (en) * | 1985-08-26 | 1994-01-25 | William A. Carter | Modulation of aids virus-related events by double stranded rnas (dsrnas) |
| PH30882A (en) * | 1987-03-03 | 1997-12-23 | Hem Res Inc | Activated Rnase L as a maker for viral infections. |
| AU1820388A (en) * | 1987-07-17 | 1989-01-19 | Hem Research, Inc. | Double stranded rna correction of aberrant metabolic pathways associated with uncontrolled tumor cell and virus growth cycles |
| EP0306347B1 (en) * | 1987-09-04 | 1995-05-10 | Hem Pharmaceuticals Corp. | Diagnosis of double-stranded RNA deficiency states |
-
1989
- 1989-04-26 EP EP89304188A patent/EP0350151B1/en not_active Expired - Lifetime
- 1989-04-26 AT AT89304188T patent/ATE103493T1/de not_active IP Right Cessation
- 1989-04-26 ES ES89304188T patent/ES2066847T3/es not_active Expired - Lifetime
- 1989-04-26 DE DE68914201T patent/DE68914201T2/de not_active Expired - Fee Related
- 1989-06-30 CA CA000604511A patent/CA1336685C/en not_active Expired - Fee Related
- 1989-07-04 DK DK332289A patent/DK332289A/da not_active Application Discontinuation
- 1989-07-04 AU AU37811/89A patent/AU3781189A/en not_active Abandoned
- 1989-07-05 IL IL9087589A patent/IL90875A/en not_active IP Right Cessation
- 1989-07-06 IE IE218089A patent/IE63927B1/en not_active IP Right Cessation
- 1989-07-06 ES ES8902387A patent/ES2018903A6/es not_active Expired - Fee Related
- 1989-07-06 ZA ZA895143A patent/ZA895143B/xx unknown
- 1989-07-06 NZ NZ229849A patent/NZ229849A/en unknown
- 1989-07-07 CN CN89106706A patent/CN1056747C/zh not_active Expired - Fee Related
- 1989-07-07 PT PT91094A patent/PT91094B/pt not_active IP Right Cessation
-
1994
- 1994-08-02 AU AU68836/94A patent/AU684288B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| DE68914201T2 (de) | 1994-07-14 |
| IL90875A (en) | 1994-04-12 |
| ES2066847T3 (es) | 1995-03-16 |
| PT91094B (pt) | 1995-01-31 |
| NZ229849A (en) | 1997-07-27 |
| ATE103493T1 (de) | 1994-04-15 |
| AU6883694A (en) | 1994-11-24 |
| ES2018903A6 (es) | 1991-05-16 |
| DK332289A (da) | 1990-01-08 |
| IE892180L (en) | 1990-01-07 |
| EP0350151A2 (en) | 1990-01-10 |
| IE63927B1 (en) | 1995-06-28 |
| DE68914201D1 (de) | 1994-05-05 |
| EP0350151A3 (en) | 1990-10-03 |
| EP0350151B1 (en) | 1994-03-30 |
| DK332289D0 (da) | 1989-07-04 |
| IL90875A0 (en) | 1990-02-09 |
| CN1039722A (zh) | 1990-02-21 |
| AU684288B2 (en) | 1997-12-11 |
| ZA895143B (en) | 1991-04-24 |
| CA1336685C (en) | 1995-08-15 |
| CN1056747C (zh) | 2000-09-27 |
| AU3781189A (en) | 1990-01-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT91094A (pt) | Metodo de diagnostico de infeccoes virais associadas com a fadiga cronica | |
| Rosin et al. | Clinical features of accidental hypothermia, with some observations on thyroid function | |
| Berman et al. | Eating attitudes in seasonal affective disorder and bulimia nervosa | |
| Cheong et al. | An epidemiological study of pityriasis rosea in Middle Road Hospital | |
| Jung et al. | Paroxysmal choreoathetosis: report of Chinese cases | |
| Michel Liet et al. | Effects of hydroxyethyl starch on cardiac output in hypotensive neonates: A comparison with isotonic saline and 5% albumin | |
| BR9007757A (pt) | Diagnostico e tratamento de disturbios neuro-cognitivos associados com disfuncoes imunologicas sistemicas | |
| Kingsley | Interferon-alpha induced ‘tertiary mania’ | |
| Llopis | THE AXIAL SYNDROME COMMON TO ALL PSYCHOSES: Part 2 | |
| SU571745A1 (ru) | Способ диагностировани хронического описторхоза | |
| Tindyebwa et al. | Diagnosing HIV | |
| Rees | An appraisal of the concept of cardiac neurosis | |
| Greenfield et al. | The SF-36 As A Measure of Substance Abusers' Health Perceptions | |
| Peters et al. | Measures of physiologic arousal preceding psychotic exacerbation in schizophrenia | |
| Padilla et al. | Human Responses to Cancer | |
| Karnad et al. | Diuretic treatment in decompensated cirrhosis and congestive heart failure: Effect of posture | |
| Roath | Managing Raynaud's phenomenon: Author's reply | |
| Petersen et al. | Factitious disease by covert phenprocoumon ingestion. Report of 16 cases. | |
| HILL et al. | 422 SEPT. 12, 1959 THE SECTIONS BRMA u | |
| Heaton et al. | Salt and the glycaemic response | |
| ROATH | P M EMME-rr | |
| Armstrong | A Long Life and a Merry One | |
| Chapnick et al. | Immunosuppressive effect of zidovudine | |
| AU578661B2 (en) | Method for diagnosis of A.I.D.S. | |
| Yu et al. | Study on relation of kidney-deficiency with hearing damage and serum trace elements in patients with chronic nephropathy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG3A | Patent granted, date of granting |
Effective date: 19940712 |
|
| MM3A | Annulment or lapse |
Free format text: LAPSE DUE TO NON-PAYMENT OF FEES Effective date: 19960131 |